References

  1. Couser WG et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-70. Google Scholar

  2. KDIGO. Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease. 201. Google Scholar

  3. Levey AS et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80(1):17-28. Google Scholar

  4. K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb; 39(2 Suppl 1):S1-266. Google Scholar

  5. Coresh J et al. Prevalence of chronic kidney disease in the United States. JAMA.2007 Nov 7; 298 (17):2038-47. Google Scholar

  6. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1-12. PubMed | Google Scholar

  7. Stevens LAS, Coresh J, Greene T et al. Assessing kidney function measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354 (23):2473-2483. Google Scholar

  8. Chen J, Wildman RP, Gu D et al. Prevalence of decreased kidney function in Chinese adults aged 35-74 years. Kidney Int.2005;68(6):2837-2845. Google Scholar

  9. Wei Chen et al. Prevalence and risk factors of chronic kidney disease: population study in the Tibetan population. Nephrol Dial. 2011; 26 (5): 1592-1599. Google Scholar

  10. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008; 51 (3): 373-384. PubMed | Google Scholar

  11. Chen W, Chen W, Wang H et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009;24 (4): 1205-1212. PubMed | Google Scholar

  12. Ingsathit A et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant.2010; 25 (5): 1567-1575. Google Scholar

  13. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003; 14 (7 Suppl 2): S131-S138. PubMed | Google Scholar

  14. Stanifer JW et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(3): p e174-81. Google Scholar

  15. Naicker S. End-stage renal disease in Sub Saharan Africa. Kidney International supplements. 2013;3:161-163. PubMed | Google Scholar

  16. Sumaili E K et al. Prevalence of chronic kidney disease in Kinshasa: results of Pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009; 24 (1): 117-122. Google Scholar

  17. Sumaili E K et al. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrology. 2009 Jul 21; 10:18. Google Scholar

  18. Henry MundongoTshamba et al. Risk of death and the economic accessibility at the dialysis therapy for the renal insufficient patient in Lubumbashi city; Democratic Republic of Congo: case series. Pan African Medical Journal. 2014;19:61. Google Scholar

  19. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine evalues in the modification of diet in renal disease study equation for estimating glomerular filtration rate .Ann Intern Med. 2006;145 (4):247-254. PubMed | Google Scholar

  20. Taal M W, Brenner B M. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney International. 2006;70(10):1694-1705. PubMed | Google Scholar

  21. Mancia G et al. ESH/ESC guidelines for the management of arterial Hypertension: the task For the management for Arterial Hypertension of the European Society for Hypertension (ESC) and European Society of Cardiology (ESC).J Hypertens. 2013 Jul;317):1281-357. PubMed | Google Scholar

  22. American Diabetesiation. Standard of medical care in diabetes 2013. Diabetes care. 2013;36(Suppl 1):511-566. Google Scholar

  23. WHO. Physical status: the use and interpretation of anthropometry. Report of WHO Expert Committee. WHO technical report series 854. Geneva; World Health Organization 1995. Google Scholar

  24. National Cholesterol Education Programme (NCEP) Expert. "Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adultes (adult treatement Panel III): Third report of the National Cholesterol Education Programme (NCEP) Expert Panel on Detection, Evaluation and treatment of High Blood Cholesterol in Adults (Adult) final report. Circulation. 2002; 106 (25): p 3143-3421. Google Scholar

  25. Catalogue francais de CYPRESS DIAGNOSTICS. Consulté le 04 Septembre 2015.

  26. Mohamed R E F et al. Profil des insuffisants rénaux chroniques diabétiques à l'initiation de l'hémodialyse au service de Néphrologie et dialyse de l'hôpital militaire de Rabat, Maroc. Pan African Médical Journal. 2013;15:124. Google Scholar
  27. Yaw AAet al.clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. Pan African Medical journal. 2014;18:274. Google Scholar

  28. Ulasi I I et al. Towards prevention of chronic kidney disease in Nigeria: on community-based study in southeast Nigeria. Kidney International supplements. 2013; 3 (2): 195-201. Google Scholar

  29. Shitu AO et al. Hematological profile of patients with chronic Kidney disease in Nigeria. Journal of Nephrology and Renal transplantation. 2013; 5(1):2-10. Google Scholar

  30. Sakandé J et al. Profil biologique de l'insuffisance rénale chronique au service de Médecine Interne du Centre Hospitalier National de Yalgado Ouédraogo d'Ouagadougou, Burkina Faso. Ann Biol Clin Qué. 2006;43(1):3-8. Google Scholar

  31. Seck S M et al. Epidemiology of chronic kidney disease in northern, Region of Senegal: a community based study in 2012. Pan African medical journal. 2014;18:307. Google Scholar

  32. Burhalter F et al. Prevalence and risk factors for chronic kidney disease in rural region of Haiti. Swiss Med Wkly. 2014;144:W14067. Google Scholar

  33. Orantes C M et al. Chronic Kidney Diseases and Associated Risk Factors in the BajoLempa Region of El Salvador Nefrolempa Study 2009. MEDICC Review. October 2011;13(4):14-22. Google Scholar

  34. Herrera et al. Clinical characteristics of chronic Kidney Disease of Non traditional causes in Salvadoran Farming Communities. MEDICC Review. 2014Apr;16(2):39-48. Google Scholar

  35. Biruh T workeneh and william E Mitch. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010 Apr; 91(4):1128S-1132S. Google Scholar

  36. Shin Y A et al. Incident chronic kidney disease and newly developed complications related to renal dysfunction in an Elderly Population during 5 years: A community-based Elderly Population cohort study. PLoS ONE. 2013;8(12): e84467. Google Scholar

  37. Moranne O, Froissart M et al. Timing of onset of CKD-Related Metabolic complications. J Am Soc Nephrol. 2009 Jan; 20(1):164-71. PubMed | Google Scholar

  38. Kamyar Kalantar-Zadeh and George R. Aronoff, Hemoglobin variarbility in Anemia of chronic kidney disease. J Am Soc Nephr .2009 Mar;20(3):479-87. Google Scholar